Article
MTHFR polymorphism and risk of periprocedural myocardial infarction after coronary stenting.
Nutrition, metabolism, and cardiovascular diseases : NMCD - 1 May 2014
Verdoia M, Schaffer A, Cassetti E, Barbieri L, Di Giovine G, Marino P, De Luca G
Abstract excerpt
BACKGROUND AND AIM: Pro-thrombotic status and platelet hyperreactivity still represent an important challenge for periprocedural myocardial infarction (PMI) after coronary stenting. Hyperhomocysteinemia has been suggested to increase the risk of cardiovascular events. The genetic variant of methylenetetrahydrofolate reductase (MTHFR) 677 C > T has been associated to reduced function of the enzyme, thus inducing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
